Apoptosis consists of highly regulated pathways involving post-translational modifications and cleavage of proteins leading to sequential inactivation of the main cellular processes. Here, we focused on the apoptotic processing of one of the essential components of the mRNA splicing machinery, the U1-70K snRNP protein. We found that at an early stage of apoptosis, before the cleavage of the C-terminal part of the protein by caspase-3, the basal phosphorylation of the Ser140 residue located within the RNA recognition motif, increases very significantly. A caspase-dependent, PP1-mediated dephosphorylation of other serine residues takes place in a subset of U1-70K proteins. The U1-70K protein phosphorylated at Ser140 is clustered in heterogeneous ectopic RNP-derived structures, which are finally extruded in apoptotic bodies. The elaborate processing of the spliceosomal U1-70K protein we identified might play an important role in the regulated breakdown of the mRNA splicing machinery during early apoptosis. In addition, these specific changes in the phosphorylation/dephosphorylation balance and the subcellular localization of the U1-70K protein might explain why the region encompassing the Ser140 residue becomes a central autoantigen during the autoimmune disease systemic lupus erythematosus. Cell Death and Differentiation (2008) In higher eukaryotes, the process of gene expression includes transcription, pre-mRNA splicing/processing and translation in the cytoplasm. The macromolecular machinery involved in pre-mRNA splicing, the spliceosome, consists of five small nuclear ribonucleoparticles (snRNPs) called U1, U2 and U4-6 snRNP, and a large number of additional splicing factors.
In higher eukaryotes, the process of gene expression includes transcription, pre-mRNA splicing/processing and translation in the cytoplasm. The macromolecular machinery involved in pre-mRNA splicing, the spliceosome, consists of five small nuclear ribonucleoparticles (snRNPs) called U1, U2 and U4-6 snRNP, and a large number of additional splicing factors. 1 Splicing factors are supposedly recruited from storage sites, that is interchromatin granules, in the interchromatin space to transcription sites at the periphery of condensed chromatin. The assembly of the spliceosome is initiated by recognition of the 5 0 splice site of pre-mRNA by U1 snRNP and mediated by serine/arginine-rich (SR) proteins. 2 Phosphorylation and dephosphorylation both have an important role in the recruitment of splicing factors and the subsequent regulation of spliceosome assembly and splicing catalysis. 3 The U1-snRNP-specific U1-70K protein is a highly phosphorylated protein, which contains two SR domains. Phosphorylation of both the SR protein ASF/SF2 and the first SR domain of the U1-70K protein are involved in vitro in their interaction. 4, 5 In addition, thiophosphorylation of the U1-70K protein, making it resistant to dephosphorylation by phosphatases, results in complete inhibition of splicing, but not of spliceosome formation. 6 At least 11-13 natural variants of the U1-70K protein, partially due to phosphorylation, have been found by 2D analysis. 7, 8 However, very little is known about specific phosphorylated residues in this protein or specific enzymes involved in the functional regulation of the U1-70K protein by phosphorylation/dephosphorylation.
Apoptosis is a fast and orderly process consisting of a sequence of steps, depending on the inducer, in which caspases play a central role. Especially caspase-3 cleaves many proteins involved in important cellular processes, such as transcription, mRNA splicing/processing and translation. 9 In addition, many kinases and phosphatases are targeted for cleavage, which can lead either to their inactivation or activation. 10 Although several spliceosomal proteins, such as the U1-70K protein, 11 are targets for caspase-3, it is unclear how the breakdown of the splicing machinery is established. Some nuclear proteins as well as their derived peptides can be followed as they are delocalized during apoptosis 12 and at a higher structural level, components of interchromatin granules, perichromatin fibrils and the nucleolus, normally present in the interchromatin space, become clustered in so-called heterogeneous ectopic RNP-derived structures (HERDS). 13 Translocation of post-translationally modified autoantigens in apoptotic bodies and the impaired processing of the latter by macrophages or dendritic cells have been considered as the possible trigger for the autoimmune response in systemic lupus erythematosus (SLE). 14, 15 The U1-70K protein, in particular the RNA recognition motif (RRM), has been identified as an important target for both autoantibodies and
CD4
þ autoreactive T cells from mice and patients with lupus. 16, 17 We previously found that a peptide encompassing residues 131-151 in the RRM of the U1-70K protein and phosphorylated at Ser140 (peptide P140) was recognized by CD4 þ T cells from mice and patients with lupus and protected young lupus mice against the disease in contrast to the nonphosphorylated peptide, which was not tolerogenic. 18, 19 In addition, for unknown reasons, the apoptotic form of the protein is a preferred target of autoantibodies. 20, 21 Consequently, we tried to clarify the pathway leading to an immunogenic protein by evaluating the changes in the phosphorylation status of the U1-70K protein during apoptotic conditions with a particular focus on Ser140. We also examined at high resolution the location of the spliceosomal U1-70K protein in apoptotic cells.
Results
Phosphorylation of Ser140 of the U1-70K protein is increased early during apoptosis. To study potential Ser140 phosphorylation of the U1-70K protein, we generated antibodies to peptide 131-151 of the U1-70K protein phosphorylated at Ser140 (further designated as anti-PhS140) and to peptide 131-151 containing a nonphosphorylated Ser140 residue (further designated as anti-S140). Western blotting analysis revealed that antiPhS140 recognized several bands between 65 and 75 kDa ( Figure 1a . Treatment of Jurkat cell extracts with increasing concentrations of alkaline phosphatase (AP) revealed the gradual decrease in the intensity of anti-PhS140 labeling of bands in the 65-75 kDa region, whereas simultaneously an increased intensity of bands in the 65-75 kDa region recognized by anti-S140 was observed ( Figure 1a ). Pre-immune sera showed no staining of either nontreated or AP-treated cell extracts (Figure 1b) . Comparable results were obtained using extracts from HeLa cells (data not shown). Therefore, the U1-70K protein recognized by anti-PhS140, is phosphorylated at Ser140, whereas anti-S140 predominantly recognizes the nonphosphorylated U1-70K protein. Next, we studied the phosphorylation level of Ser140 of the U1-70K protein in Jurkat cells after induction of apoptosis by camptothecin (CPT). We observed an increase in the phosphorylation of Ser140 very early after the induction of apoptosis (Figure 1c and d). The increase of anti-PhS140 staining was observed differently for each U1-70K variant, that is, within 1 h (variant 1), after 2 h (variant 3) or after 6 h (variant 4). Variant 2, only recognized by anti-S140, showed no significant changes after induction of apoptosis. The increase in phosphorylation of Ser140 was detectable before the cleavage of the U1-70K protein, as can be seen by the appearance of a 40 kDa cleavage fragment after approximately 3 h (Figure 1c, arrow) . Interestingly, the 40 kDa cleavage fragment of the U1-70K protein was only recognized by anti-PhS140 and not by anti-S140, suggesting that this fragment is phosphorylated at Ser140. Pre-immune sera did not show recognition of extracts from apoptotic cells (Figure 1b) . The increase in phosphorylation of Ser140 also occurred before the cleavage and activation of caspase-3 and the subsequent cleavage of PARP-1 by caspase-3 ( Figure 1c ). In addition, Ser140 phosphorylation occurred before the appearance of extensive membrane blebbing (Figure 1e ) and the appearance of phosphatidylserine at the cell surface (Figure 1f) . Therefore, an increased phosphorylation of several U1-70K protein variants at Ser140 seems to be an early event during apoptosis.
Other residues in the U1-70K protein are dephosphorylated during apoptosis. We probed western blots of AP-treated Jurkat (Figure 2 Figure 2a) . Together, these results led us to conclude that variant 5 represents a minimal phosphorylated U1-70K protein and that simultaneously to the phosphorylation of Ser140, an extensive dephosphorylation of other serine residues of the U1-70K protein occurs during apoptosis.
Apoptosis-linked dephosphorylation of the U1-70K protein is caspase-dependent. We added the caspase inhibitor DEVD after induction of apoptosis by CPT and tested the effect on the phosphorylation status of the U1-70K protein. Addition of DEVD at a concentration of 20 mM could inhibit the appearance of variant 5 and, as expected, the cleavage of the U1-70K protein (Figure 3a and c) . Analysis of the same extracts with an anti-PARP-1 antibody also showed the inhibition of PARP-1 cleavage (Figure 3b ). In contrast, we could not detect a significant effect on the apoptosisassociated phosphorylation of Ser140 (data not shown). Although addition of a low concentration (2 mM) of DEVD completely inhibited the appearance of variant 5, we still found cleavage of the U1-70K protein but found no effect on the amount of cells with extensive apoptotic blebbing. This suggests that the apoptosis-associated dephosphorylation is not directly related to cleavage of the U1-70K protein or to the progression of apoptosis.
In addition, we tested the effect of dephosphorylation of the U1-70K protein on its cleavage by recombinant caspase-3 in vitro. We found no difference in the susceptibility to PP1 is involved in the apoptosis-linked dephosphorylation of the U1-70K protein. As serine/threonine protein phosphatases PP1 and PP2A have been implicated in the regulation of apoptosis 22 and the regulation of spliceosome assembly and the splicing reaction, 23, 24 we evaluated the possible involvement of these phosphatases in the apoptosis-associated dephosphorylation of the U1-70K protein. Addition of the PP1-specific inhibitor tautomycetin (TMC) resulted in a dose-dependent inhibition of dephosphorylation of the U1-70K protein in CPT-treated cells (Figure 4a and b) . Note in particular that variant 5 disappeared and that variant 4 persisted. In contrast, addition of okadaic acid (OA) at a concentration leading to a specific inhibition of PP2A (0.1 nM) resulted in an enhanced dephosphorylation of the U1-70K protein compared with cells treated with CPT only. Note in particular that compared with nontreated cells shown in the first lane, the intensity of variant 5 increased, whereas the variant 4 completely disappeared. We found no difference when increasing concentrations of OA were used. TMC and OA showed no effect on cleavage of the U1-70K protein (arrow) or on the percentage of cells with extensive membrane blebbing at these concentrations (Figure 4a and b) . We also tested the PP2B inhibitor cyclosporine A (CsA), which resulted in a barely detectable increase of dephosphorylation of the U1-70K protein (Figure 4a ). However, CsA treatment resulted in an increase in apoptosis observed by an increase in the number of cells with extensive membrane blebbing. Next, we incubated Jurkat cells for different time periods with CPT and with or without 0.1 mM of the PP1 inhibitor TMC (Supplementary Figure 3) . It appeared that inhibition of PP1 lowered the rate of U1-70K dephosphorylation after induction of apoptosis.
Next, we used mAb2.73 to immunoprecipitate U1-70K protein-containing complexes from extracts of nontreated or CPT-treated Jurkat cells (Figure 4c ). We found that PP1 was not co-precipitated by mAb2.73 in extracts of nontreated cells (lane 2). However, PP1 was co-precipitated at 8 h after apoptosis induction (lane 4). This kinetics correlated with the appearance of variant 5. The presence of PP1 in the complex precipitated by mAb2.73 decreased after 16-24 h of apoptosis (lane 5-6), when we also observed no further increase in the intensity of variant 5. Conversely, we performed the immunoprecipitation using an anti-PP1 antibody (Figure 4d ). Two variants of the U1-70K protein co-precipitated with PP1 in extracts from CPT-treated Jurkat cells (lane 2), but not in extracts from nontreated cells (lane 1). Note that under the applied conditions, PP1 could be precipitated only from extracts of apoptotic cells and not from extracts of nonapoptotic cells. This could be due to an increased expression of PP1 during early apoptosis (data not shown). Finally, we found a dose-dependent decrease in the molecular mass of several U1-70K variants (particularly variant 1) and the appearance of variant 5 in extracts of nontreated cells incubated with increasing concentrations of recombinant PP1 (Figure 4e) . Together, we demonstrate the involvement of PP1 in the apoptosis-linked dephosphorylation of the U1-70K protein.
The U1-70K protein phosphorylated at Ser140 is present in perichromatin fibrils and clusters in HERDS during apoptosis. To study the localization of the U1-70K protein phosphorylated at Ser140 in nonapoptotic and apoptotic cells we used mAb2.73 and anti-PhS140 for labeling in immune fluorescence and electron microscopy. In nonapoptotic cells, we found that anti-PhS140 stained particular speckles in the nucleus (Figure 5a ). Anti-PhS140-positive speckles were mostly located at the periphery of regions staining with high intensity for mAb2.73. In apoptotic cells, we found an evident change in the localization of the U1-70K protein phosphorylated at Ser140, which localized in large clusters also positive for mAb2.73. U1-70K-containing clusters were positive for the proliferation-associated nuclear antigen (PANA), a specific marker for interchromatin granules (Figure 5b and c) .
Interchromatin granules (sites of splicing factors storage) and perichromatin fibrils (sites of transcription and mRNA splicing) can be observed in electron microscopy. 25 In apoptotic cells, these structures cluster in HERDS. 26 We observed changes in chromatin structure and the formation of HERDS (arrowheads) after incubation with CPT for 3 h (Figure 6a-d) . Initially, chromatin had a spongy structure, which still surrounded some HERDS (panel b). Then a complete separation of chromatin and HERDS occurred while the nuclear membrane was still intact (panel c) and finally, the nuclear membrane was degraded and chromatin and HERDS were released into the cytoplasm (panel d). Staining of nontreated cells with mAb2.73 showed localization of the U1-70K protein both in interchromatin granules and perichromatin fibrils (Figure 6e ). In contrast, anti-PhS140 revealed the presence of the U1-70K protein phosphorylated at Ser140 almost only in perichromatin fibrils (Figure 6f ). In apoptotic (Figure 6g-j) . The labeling with these two antibodies was found almost exclusively at the periphery of the HERDS where interchromatin granules and perichromatin fibrils are still morphologically recognizable.
We found that PP1 was localized in the clusters extruded from chromatin in apoptotic cells using immune fluorescence microscopy. These PP1-positive clusters were often associated with clusters containing the U1-70K protein phosphorylated at Ser140 (Figure 7a and b) and PANA (Figure 7c ). In contrast, PP2A was not specifically associated with these clusters (Figure 7d ).
The U1-70K protein present in apoptotic bodies is phosphorylated at Ser140. As apoptotic blebs/bodies contain many antigens recognized by lupus autoantibodies, 27, 28 we isolated apoptotic bodies from Jurkat cells after incubation with CPT for 48 h as described in Materials and Methods. Western blot analysis revealed the presence of the 40 kDa fragment of the U1-70K protein in these isolated apoptotic bodies, whereas we could hardly detect any intact phosphorylated or hypophosphorylated U1-70K protein (Figure 8a ). We found a very strong recognition of the 40 kDa cleavage fragment by anti-PhS140 compared with antipeptide 183-202. In addition, AP treatment of the extracts from apoptotic bodies resulted in a decreased binding to the 40 kDa cleavage fragment of the U1-70K protein by anti-PhS140 (Supplementary Figure 4) . Similar results were found for apoptotic bodies isolated from anti-FAS-treated cells (data not shown). We also identified PP1 in isolated apoptotic bodies (Figure 8b ). Immune fluorescence microscopy revealed that the (apoptotic cleaved) U1-70K protein (Figure 8c -e) was present in apoptotic bodies as clusters. Staining by anti-PhS140 and mAb2.73 showed a partial colocalization in the same clusters. We found that a single apoptotic body contained DNA and the U1-70K protein in separate clusters (Figure 8c and e) or that only one of these nuclear components was present in a single apoptotic body (Figure 8d) . Therefore, we conclude that the U1-70K protein present in apoptotic bodies has undergone the apoptosis-associated changes described above, that is, phosphorylation of Ser140, dephosphorylation of additional residues, cleavage by caspase-3 and clustering inside HERDS.
Discussion
Our results demonstrate that the spliceosomal U1-70K protein undergoes specific changes in its phosphorylation status and subcellular localization early during apoptosis, in addition to the previously described cleavage by caspase-3 (summarized in Supplementary Figure 5) . These apoptosis-linked changes target the functional domains of the protein, that is, the RRM, the SR domains and the C terminus. As the U1-70K protein is an essential protein in the U1 snRNP particle, which is involved in the first steps of the splicing reaction 1 and directly associated with transcription, 29 these modifications implicate an important role for this protein in a novel pathway involving the breakdown of the mRNA splicing machinery early during apoptosis. In addition, we show that the main target of Phosphorylation of Ser140 in the U1-70K RRM. We identified a novel phosphorylation site at Ser140 in the RRM of the U1-70K protein. The U1-70K protein phosphorylated at Ser140 is present on perichromatin fibrils, where transcription and mRNA splicing take place. In contrast, we did not find such phosphorylated U1-70K protein in the interchromatin granules (involved in the storage and assembly of snRNPs). The Ser140 residue is located in the helix b2-helix b3 loop that is involved in the binding to U1 RNA according to a model of the homologous RRM in the spliceosomal U1A protein. 30 Therefore, an intriguing possibility arises that the phosphorylation of Ser140, by a so far unidentified kinase, plays a role in the regulation of the U1-70K protein during mRNA splicing, by affecting its binding to U1 RNA. The increase in phosphorylation of Ser140 we observed early during apoptosis could then be associated with a change in mRNA splicing activity required for the progression of apoptosis. The exact role of Ser140 phosphorylation is currently under investigation.
A novel role for PP1 in the apoptosis-associated dephosphorylation of the U1-70K protein. We show here that at least four different variants of the U1-70K protein can be observed by SDS-PAGE between 65 and 75 kDa, which represent different phosphorylation states of the U1-70K protein. During apoptosis, we observed the Figure 6 During apoptosis U1-70K phosphorylated at Ser140 is present in HERDS. (a-d) Morphological study of the nuclear changes by electron microscopy of nontreated (a) or CPT-treated Jurkat cells (3 h, b-d) showing the condensation and fragmentation of chromatin and the formation of HERDS (arrowheads). Different stages of the separation of RNP-derived structures from chromatin could be observed; initially chromatin had a spongy structure, which still surrounded some HERDS (b), then a complete separation of chromatin and HERDS occurred while the nuclear membrane was still intact (c) and finally, the nuclear membrane was degraded and chromatin and HERDS were released into the cytoplasm (d). Scale bar, 2 mm. (e-f) Electron microscopy immunolabeling of the nucleus of Jurkat cells with mAb2.73 (e) or anti-PhS140 (f). The gold particles are present on the interchromatin granules (IG) and perichromatin fibrils (PF) for mAb2.73 and only in perichromatin fibrils for anti-PhS140. Scale bar, 100 nm. (g-j) Immunolabeling by mAb2.73 (g, h) and anti-PhS140 (I, j) in electron microscopy shows the localization inside HERDS. Scale bar, 500 nm (g, i) or 200 nm (h, j). Note that the HERDS visible in panel g are still located in the nucleus (nuclear membrane indicated by arrowheads). Bernhard's EDTA regressive technique was used to bleach the chromatin in panels e-j appearance of a protein band at approximately 60 kDa (variant 5), representing a minimal phosphorylated form of the U1-70K protein. The 40 kDa fragment also seems minimally phosphorylated, as we found no effect of prolonged PP1 or AP treatment on the molecular mass of this fragment. Dephosphorylation of the U1-70K protein seems not necessary for cleavage by caspases; however, caspase activation is absolutely required for the dephosphorylation of the U1-70K protein. In addition, cleavage of SR protein kinases (SRPKs) by caspases leading to inactivation of these enzymes 31 could result in a decreased phosphorylation rate of the protein. Interestingly, the observed increase of the dephosphorylation by inhibition of PP2A can be explained by an effect on the phosphorylation rate of the U1-70K protein, as dephosphorylation of the SR kinase Clk1 by PP2A increases its activity. 32 The extensive dephosphorylation of the protein during apoptosis will most likely affect the first SR domain, as 10/19 potential serine phosphorylation sites (as predicted by NetPhos 2.0) are located in this domain.
Serine/threonine phosphatases PP1, PP2A and PP2Cg are each involved in specific stages of spliceosome assembly and essential for completing the splicing reaction. 23, 24 Our results show a novel role for PP1 in the dephosphorylation of the spliceosomal U1-70K protein during apoptosis. Interestingly, PP1 is also involved in the dephosphorylation of SR proteins during anti-FAS-induced apoptosis. 33 Therefore, PP1-mediated dephosphorylation of the SR domains in both proteins early during apoptosis could result in the loss of the phosphorylation-dependent interaction between these proteins. Consequently, the described SR protein-mediated binding of the U1-70K protein (and the U1 snRNP particle) to RNA polymerase II, the 5 0 splicing site and the U2 snRNP particle would be affected. Our data suggest that PP1 is involved in the dephosphorylation of certain phospho-variants of the U1-70K protein during apoptosis. In addition, we found no effect of PP1 inhibition on the molecular mass of the 40 kDa fragment. Therefore, additional phosphatases could be involved, which, as shown, are most likely not PP2A and PP2B.
Interestingly, we found a high expression of PP1 in clusters associated with HERDS. The activation of PP1 and the inactivation of SRPKs (which are associated with the release of SR proteins from interchromatin granules) could play an important role in the clustering of splicing proteins and the formation of HERDS. Indeed, accumulation of splicing factors upon inhibition of transcription (which also induces the formation of HERDS) requires PP1 activity. 34 Further study has to evaluate the relation between the phosphorylation status of the U1-70K protein, its subcellular localization and the composition of the U1-70K-containing complex. So far, the different kinetics of the apoptosis-linked phosphorylation/ dephosphorylation for each U1-70K variant suggests a different availability for specific kinases and phosphatases.
Role of apoptosis-linked modifications of the U1-70K protein in autoimmunity. Knowledge of the detailed processing of RNA-and DNA-binding proteins during apoptosis is important for the understanding of the autoimmune response in SLE. In this study, we show that the apoptotic U1-70K protein is relocated early during apoptosis and clustered inside HERDS, 26 which are finally released in apoptotic bodies. When considering the high resistance to protease and nuclease digestion shown for interchromatin granules, it is not unlikely that neo-epitopes associated with HERDS, which are structurally based on interchromatin granules, 13 are protected from degradation. Importantly, the apoptosis-associated change in phosphorylation we identified involves the RRM of the U1-70K protein, which is the main target of SLE autoantibodies and autoreactive T cells. 16, 17, 20, 21 In addition, we have previously reported the importance of the phosphorylated Ser140 residue in modulating the autoimmune response. 18, 19 Therefore, we propose that the Materials and Methods Antibodies. Antibodies against peptides encompassing residues 131-151, the residues 131-151 with a phosphorylated Ser140 and 183-202 (containing no serine residues) of the U1-70K protein were raised in rabbits. Other antibodies used were mAb2.73 (anti-U1-70K, recognizing RD repeats in the 230-240 region of the U1-70K protein), 35 anti-PARP, 36 anti-caspase-3 (BD Biosciences, Erembodegem, Belgium), anti-actin (BD Transduction Laboratories), anti-PANA (Biogenex, San Ramon, USA), anti-PP1 and anti-PP2a-Calpha (both Santa Cruz Biotechnology, Santa Cruz, USA).
Induction of apoptosis and use of caspase and phosphatase inhibitors. Apoptosis was induced by incubating Jurkat or HeLa cells with 2.5 mg/ml of topoisomerase I inhibitor CPT (Sigma, Steinheim, Germany) or 2 mg/ml IgM anti-FAS antibody clone 7C11 (Beckman Coulter, Fullerton, USA) for the indicated times. For inhibition of caspases Z-DEVD-fmk (EMDBiosciences, San Diego, USA) was used. For inhibition of serine/threonine phosphatases PP1, PP2A or PP2B, the indicated concentrations of TMC, OA or CsA (all from EMDBiosciences), respectively, were used. Apoptosis was measured by double staining of Annexin V-allophycocyanin (BD Biosciences) and PI using a FACSCalibur flow cytometer (BD Biosciences).
Immune precipitation, SDS-PAGE and western blotting. Cell extracts were prepared by lysing PBS-washed pelleted cells in lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl 2 , 0.5% Igepal) supplemented with phosphatase inhibitors NaF (1 mM) and NaVa (1 mM) and a cocktail of protease inhibitors (Sigma), and sonicated. Apoptotic bodies were prepared as described previously. 37 Shortly, apoptosis was induced in Jurkat cells as described above for 48 h and cell culture supernatant was collected. Two additional centrifugation steps (800 Â g) were performed to remove remaining cells and the supernatant was centrifuged at 17500 Â g for 20 min. The pellet containing apoptotic bodies was analyzed in flow cytometry and showed a distinct population positive for Annexin-V and PI. Representative microscopic pictures of isolated apoptotic bodies are shown in Figure 8 . Extracts from isolated apoptotic bodies were prepared in the lysis buffer described above. Protein concentration of the prepared extracts was determined by the bi-cinchoninic acid assay (Sigma) with BSA as a standard. For immune precipitation 5 mg of antibody was added to 200 mg cell extract in a total volume of 150 ml lysis buffer containing 150 mM NaCl, and incubated overnight at 41C. A 30-ml volume of Protein A-Sepharose and 170 ml of lysis buffer containing 150 mM NaCl were added and incubated overnight at 41C. Sepharose beads were washed five times with lysis buffer containing 150 mM NaCl and two times with PBS. Precipitated proteins were eluted by adding 50 ml sample buffer (50 mM Tris-HCl pH 7.4, 6 M urea, 3% SDS and 6% freshly added b-mercaptoethanol).
Cell extracts (5-15 mg of protein) were resolved by SDS-PAGE and proteins were transferred to nitrocellulose sheets. Blots were blocked with 5% milk (w/v) in TBS-0.05% Tween 20 (TBS-T). Incubation with the primary antibody was performed for 2 h in TBS-T, followed by washing and incubation for 2 h with the corresponding horseradish peroxidase-labeled secondary antibody (Jackson ImmunoResearch, Suffolk, UK). For western blots of immune precipitation experiments, TrueBlot secondary antibodies specific for intact IgG (eBioscience, San Diego, USA) were used. Proteins were visualized using ECL (Amersham Biosciences, Buckinghamshire, UK). Exposed films were quantified by ImageJ software.
Treatment with alkaline phosphatase, recombinant caspase-3 or PP1. Cell extracts were prepared using the lysis buffer described above, without the addition of phosphatase inhibitors. To 150 mg extract, 1 mM MgCl 2 was added together with the indicated units of AP (Zymed, San Francisco, USA) for 2 h at 371C. As a control, another sample of the extract was incubated without AP, but with 1 mM NaF and 1 mM Na 3 VO 4 . For the treatment with caspase-3, 10 ml of AP-treated extract or control extract was incubated with 1000 U recombinant human caspase-3 (EMDBiosciences) in caspase-buffer (100 mM NaCl, 50 mM HEPES, 10 mM DTT, 1 mM EDTA, 10% glycerol and 0.1% CHAPS; pH 7.0) for 2 h at 371C. PP1 treatment was performed by adding the indicated units of recombinant PP1 (EMDBiosciences) to U1-70K protein precipitated by mAb2.73 in a total volume of 20 ml of PP1-assay buffer (50 mM Tris-HCl, 5 mM DTT, 200 mM MnCl 2 , 100 mM EDTA and 200 mg/ml BSA, pH 7.0) and incubated overnight at 371C.
Immune fluorescence microscopy. Cells were fixed with freshly made 2% paraformaldehyde in phosphate buffer (PB) for 1 h at room temperature (RT). The cells were then washed in TBS, incubated with mAb2.73 (1 : 10), anti-PANA (1 : 3), anti-PhS140 (1 : 10), anti-PP1 (1 : 50) or anti-PP2A (1 : 10) and subsequently incubated with the corresponding Alexa-conjugated secondary antibodies (Molecular Probes, Eugene, USA). Pictures were obtained with a Zeiss fluorescence microscope (Axiovert 200 M) using a Â 63 magnification. Images were acquired with a digital camera using Axiovision 4.37 software (Zeiss, Le Pecq, France). Images were contrast-enhanced by applying the brightness/contrast regulation of Photoshop 8.0 software to the whole image. Double immunofluorescence images were obtained by superimposing two single-color pictures with Adobe Photoshop.
Electron microscopy. For immunoelectron microscopy, samples of normal and apoptotic Jurkat cells were fixed with 4% paraformaldehyde in PB for 1 h at RT and rinsed in TBS. Samples were then imbedded in 2% low gelling agarose and placed into 0.5 M NH 4 Cl/PBS for 30 min at 41C, dehydrated in ethanol at RT and embedded in LR White resin. Ultrathin sections were incubated with normal goat serum (NGS) diluted 1 : 100 in TBS for 3 min. mAb2.73 (1 : 10) and anti-PhS140 (1 : 10) diluted in TBS containing 0.05% Tween 20 and 0.1% BSA, were incubated overnight at 41C. After rinsing with TBS-Tween and TBS, samples were incubated with NGS. The appropriate secondary antibody coupled to colloidal gold (Aurion, Wageningen, The Netherlands) was diluted 1 : 20 in TBS and incubated for 30 min at RT. As a control, grids were incubated without primary antibody. Finally, samples were rinsed with TBS and distilled water, and stained with Bernhard's EDTA regressive technique, 38 which preferentially stains RNP-containing nuclear components.
For ultrastructural morphology, samples of normal and apoptotic Jurkat cells were fixed with 2.5% glutaraldehyde in PB for 2 h, rinsed in PB and postfixed in 2% OsO 4 for 30 min. The specimens were imbedded in 2% low gelling agarose, dehydrated in ethanol at RT and embedded in DURCURPAN resin. Samples were inspected with a Hitachi H600 electron microscope and images were acquired using a Hamamatsu CCD camera.
